JOURNAL OF CLINICAL SURGERY ›› 2026, Vol. 34 ›› Issue (3): 249-252.doi: 10.3969/j.issn.1005-6483.20260061
Previous Articles Next Articles
LI Wen*,ZHANG Zhoujing,SUN Dawei
Received:
Online:
Published:
Abstract: Thyroid cancer is the fastest-growing solid malignant tumor in China over the past decade,with bottlenecks of missed diagnosis and overtreatment throughout its diagnosis and treatment.Artificial intelligence(AI) has been deeply integrated into the full process.In diagnosis,AI enhances ultrasound and contrast-enhanced cervical CT,bridging physicians' clinical experience gaps and improving diagnostic accuracy.During surgery,AI combined with endoscopic navigation protects key intraoperative structures and assists frozen section diagnosis to increase lymph node metastasis prediction accuracy.In prognosis management,AI-based models enable precise drug delivery,real-time monitoring,and optimized treatment outcomes with 3D printing and wearable devices.AI is transforming from an "auxiliary tool" to a "diagnostic and therapeutic collaborative partner".To address AI limitations,future measures including multi-center databases and technology translation will advance diagnosis and treatment toward a "precision,individualization,and intelligence" paradigm,improving patients' survival rates and quality of life.
Key words: thyroid cancer; artificial intelligence; entire diagnostic and therapeutic workflow; precision medicine
LI Wen*,ZHANG Zhoujing,SUN Dawei. Breaking the deadlock in thyroid cancer diagnosis and treatment:A new paradigm of artificial intelligence in clinical application[J].JOURNAL OF CLINICAL SURGERY, 2026, 34(3): 249-252.
0 / / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: http://www.lcwkzz.com/EN/10.3969/j.issn.1005-6483.20260061
http://www.lcwkzz.com/EN/Y2026/V34/I3/249
Cited